Occudo Quantitative Strategies LP Travere Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$22.91 - $28.63 $622,075 - $777,390
-27,153 Reduced 42.44%
36,821 $907,000
Q2 2022

Aug 15, 2022
BUY
$20.94 - $30.01 $803,446 - $1.15 Million
38,369 Added 149.85%
63,974 $1.55 Million
Q1 2022

May 16, 2022
BUY
$23.61 - $30.6 $604,534 - $783,513
25,605 New
25,605 $660,000

Others Institutions Holding TVTX

# of Institutions
196
Shares Held
84.9M
Call Options Held
776K
Put Options Held
900K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.3B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email